|
gptkbp:instanceOf
|
gptkb:vaccine
|
|
gptkbp:administeredBy
|
intramuscular injection
|
|
gptkbp:age
|
6 months and older
|
|
gptkbp:alsoKnownAs
|
gptkb:Moderna_COVID-19_Vaccine
gptkb:Spikevax
|
|
gptkbp:approvedBy
|
gptkb:WHO
gptkb:FDA
gptkb:EMA
|
|
gptkbp:boosterDoseInterval
|
at least 5 months after second dose
|
|
gptkbp:boosters
|
yes
|
|
gptkbp:CDCRecommended
|
yes
|
|
gptkbp:clinicalTrialPhase
|
July 2020
|
|
gptkbp:contains
|
mRNA encoding SARS-CoV-2 spike protein
|
|
gptkbp:containsAdjuvant
|
no
|
|
gptkbp:containsEggProducts
|
no
|
|
gptkbp:containsLatex
|
no
|
|
gptkbp:containsMeat
|
no
|
|
gptkbp:containsPreservatives
|
no
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Moderna
|
|
gptkbp:distribution
|
global
|
|
gptkbp:efficacyAgainstOriginalStrain
|
~94%
|
|
gptkbp:EMARecommended
|
yes
|
|
gptkbp:emergencyServices
|
December 2020
|
|
gptkbp:emergencyUseCountries
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:Japan
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:form
|
2 doses
|
|
gptkbp:fullApprovalDate
|
January 2022
|
|
gptkbp:includedInCOVAX
|
yes
|
|
gptkbp:manufacturer
|
gptkb:Moderna,_Inc.
|
|
gptkbp:patent
|
gptkb:Moderna,_Inc.
|
|
gptkbp:pregnancyCategory
|
consult healthcare provider
|
|
gptkbp:primarySeriesInterval
|
28 days between doses
|
|
gptkbp:sideEffect
|
fever
fatigue
headache
muscle pain
chills
injection site pain
|
|
gptkbp:storage
|
-20°C
|
|
gptkbp:target
|
gptkb:COVID-19
|
|
gptkbp:technology
|
gptkb:vaccine
|
|
gptkbp:variantBoosterAvailable
|
yes
|
|
gptkbp:variantBoosterType
|
bivalent (Omicron-containing)
|
|
gptkbp:WHOEmergencyUseListing
|
April 2021
|
|
gptkbp:bfsParent
|
gptkb:Moderna
|
|
gptkbp:bfsLayer
|
4
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
mRNA-1273
|